Can psychiatry cross the quality chasm? Improving the quality of health care for mental and substance use conditions

被引:84
作者
Pincus, Harold Alan
Page, Ann Ex
Druss, Benjamin
Appelbaum, Paul S.
Gottlieb, Gary
England, Mary Jane
机构
[1] Columbia Univ, Dept Psychiat, New York, NY 10032 USA
[2] New York Presbyterian Hosp, New York, NY USA
[3] RAND Corp, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA
[5] Natl Acad Sci, Inst Med, Washington, DC 20418 USA
[6] Emory Univ, Atlanta, GA 30322 USA
[7] Brigham & Womens Hosp, Boston, MA 02115 USA
[8] Regis Coll, Boston, MA USA
关键词
D O I
10.1176/appi.ajp.164.5.712
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In 2001, a seminal Institute of Medicine report, Crossing the Quality Chasm: A New Health System for the 21st Century, put forth a comprehensive strategy for improving the quality of U.S. health care. This strategy attained considerable traction within the overall U.S. health care system and subsequent attention in the mental health community as well. A new Institute of Medicine report, Improving the Quality of Health Care for Mental and Substance Use Conditions, examines the quality chasm strategy in light of the distinctive features of mental and substance use health care, including concerns about patient decision-making abilities and coercion into care, a less developed quality measurement and improvement infrastructure, lagging use of information technology and participation in the development of the National Health information Infrastructure, greater separations in care delivery accompanied by more restrictions on sharing clinical information, a larger number of provider types licensed to diagnose and treat, more solo practice, and a differently structured marketplace. This article summarizes the Institute of medicine's analysis of these issues and recommendations for improving mental and substance use health care and discusses the implications for psychiatric practice and related advocacy efforts of psychiatrists, psychiatric organizations, and other leaders in mental and substance use health care.
引用
收藏
页码:712 / 719
页数:8
相关论文
共 40 条
[1]  
[Anonymous], SAF TRAIN TOOLS ROCK
[2]  
BATES DW, 2003, PSYCHIAT SERV, V54, P1
[3]   Disseminating innovations in health care [J].
Berwick, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (15) :1969-1975
[4]   The schizophrenia PORT pharmacological treatment recommendations: Conformance and implications for symptoms and functional outcome [J].
Buchanan, RW ;
Kreyenbuhl, J ;
Zito, JM ;
Lehman, A .
SCHIZOPHRENIA BULLETIN, 2002, 28 (01) :63-73
[5]  
Butler SF, 2001, PSYCHOL ADDICT BEHAV, V15, P4
[6]   Changes in methadone treatment practices - Results from a national panel study, 1988-2000 [J].
D'Aunno, T ;
Pollack, HA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :850-856
[7]   Improving general medical care for persons with mental and addictive disorders: systematic review [J].
Druss, BG ;
von Esenwein, SA .
GENERAL HOSPITAL PSYCHIATRY, 2006, 28 (02) :145-153
[8]  
*DUK U, 2006, DUK U PROGR ADV PSYC
[9]   The revised behavior and symptom identification scale (BASIS-R) - Reliability and validity [J].
Eisen, SV ;
Normand, SL ;
Belanger, AJ ;
Spiro, A ;
Esch, D .
MEDICAL CARE, 2004, 42 (12) :1230-1241
[10]   Screening and intervention for illicit drug abuse - A national survey of primary care physicians and psychiatrists [J].
Friedmann, PD ;
McCullough, D ;
Saitz, R .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (02) :248-251